Producing Craft Concentrates: Q&A with Precision Extraction Solutions

Producing Craft Concentrates: Q&A with Precision Extraction Solutions

While THC and CBD come from the same plant, processing cannabis and processing hemp are two unique cases that require thoughtful consideration in the planning phase to execute each extraction procedure successfully.

The main differing factor between cannabis and hemp extraction is the throughput requirement. Generally speaking, hemp processors will have a much greater processing demand than cannabis processors.

From equipment selection to best practices and safety considerations, here is what to consider when processing cannabis and hemp.

Selecting the Right Equipment

Equipment selection will be dependent on specific goals and will differ marginally for each project.

Processing hemp/CBD requires ethanol-based extraction equipment, such as a centrifuge, as well as supporting solvent recovery equipment, such as a rising/falling film evaporator or a rotary evaporator.

CBD extraction also requires distillation equipment, such as a wiped film distillation unit or a short path apparatus, as well as crystallization equipment, such as a jacketed reactor and temperature control units.

Processing hemp may also require drying ovens and filtration equipment, depending on the desired finished products.

Cannabis/THC extraction is primarily a hydrocarbon-based process that uses a closed-loop system and residual solvent removal, such as vacuum drying ovens.

As with hemp/CBD extraction, processing cannabis requires distillation equipment, as well as post-processing equipment like glassware, a jacketed reactor, or a “diamond mine,” which again depends on the desired finished products.

Precision Extraction: Hemp … by sandydocs on Scribd

 

Best Practices

Each extraction process has similar parameter considerations that must be determined when executing the primary extraction process. The three significant parameters are time, temperature, and pressure.

Time refers to the amount of time that the solvent is allowed to interface with the material. This is commonly referred to as the soak, dwell, or residence time.

Temperature refers to the temperature of the primary extraction solvent as it interfaces with the material. The material temperature is also essential, and the material should ideally be stored and prepared at a similar temperature to the extraction solvent to reduce the overall delta between the two inputs.

Pressure refers to the pressure acting on both the material and the solvent during the primary extraction phase. This can relate to the vapor pressure of the solvents of choice or, in some cases, an inert gas like nitrogen may be used to increase vessel pressure if desired.

Each of these three variables can be manipulated to achieve a desired outcome. Skilled operators can gauge which parameters need to be adjusted to meet their goals on the fly, based on the output quality.

Input quality is the single largest variable when it comes to output quality. The quality of your starting material will determine the theoretical maximum quality of your finished products in most cases.

In instances of compound isolation or refinement via distillation, this has less merit. However, when creating full-spectrum hemp products or live resin cannabis concentrates, input material quality plays the most considerable role of any single parameter when determining the quality of the finished product.

Safety & Compliance Considerations

The safety and compliance considerations that must be taken into account vary dramatically from solvent to solvent, which is one of the reasons that ethanol is preferred for large-scale processing operations in favor of hydrocarbon-based primary extraction systems.

Solvent volatility, flammability, operational pressure, maximum allowable storage quantities, and operating environment classifications all need to be carefully considered during the design and equipment selection phase of any compliant extraction lab project, regardless of scale or primary extraction method.

Published at Tue, 26 May 2020 20:29:00 +0000

Neptune Wellness Solutions Inc (NASDAQ:NEPT) Expects To Post Revenues Of $22 Million In Q1 2021: Introduces Non-Contact Infrared Thermometer – Neptune Air

Neptune Wellness Solutions Inc (NASDAQ:NEPT) Expects To Post Revenues Of $22 Million In Q1 2021: Introduces Non-Contact Infrared Thermometer – Neptune Air

Neptune Wellness Solutions Inc (NASDAQ:NEPT) expect to report revenues of $29.6 million (up 21%) in 2020. The company expects to report revenues of $22 million (up 440%) in Q1 2021. It is on the backdrop of rapidly expanding its wellness and health solutions and adapting to the changing market conditions.

Introduces Neptune Air

Neptune recently introduced Neptune Air, a non-contact infrared thermometer, and hand sanitizers. The company also leverages its economical and highly flexible supply chain and takes advantage of third-party manufacturers and in-house production to scale up production to meet the market demand. New capacity expansions are helping the company to improve its revenues.

Neptune Air helps to measure the temperature of a person and reduces the risk of contamination and disease spreading. The company will provide different versions of Neptune Air for government customers, businesses, and consumers. Benefits of Neptune Air include easy to use, displays temperature readings quickly, and facilitates repeat measurements.

CEO of Neptune, Michael Cammarata, said Neptune Air showcases its ability to respond quickly to the needs of consumers. Neptune Air strengthens the leadership of Neptune in the health and wellness segment. It opens the door to the wellness and health market and grows its leadership and capabilities to meet the growing needs. The company is excited to introduce Neptune Air and address supply constraints. Michael said the company expects to report strong results in Q1 2021 because of growing demand in all distribution channels.

Key growth drivers and corporate update

Neptune has introduced Ocean Remedies and Forest Remedies. D2C consumer operations have also supported new brand development. The company has developed hand sanitizer products and bagged retail orders to support growth.

Neptune entered a pact with Dr. Jane Goodall, a renowned wildlife conservationist, to develop natural health and wellness products and introduce it under the brand ‘Forest Remedies.’ Its phase II expansion of the Sherbrooke facility is operational and added a new extraction business.

Neptune has strengthened its sales, operations, and management teams by recruiting professionals, who worked at companies like Hanes, Colgate Palmolive, SmartyPants Vitamins, Unilever, and MediPharm. The new initiatives helped the company to win new customers and enhance production levels.

Published at Mon, 25 May 2020 12:47:54 +0000

Green Peak Innovations and Last Prisoner Project to Launch Two Joints Brand to Fund Criminal Justice Reform Efforts

Green Peak Innovations and Last Prisoner Project to Launch Two Joints Brand to Fund Criminal Justice Reform Efforts

The week of May 24, Michigan’s vertically integrated Green Peak Innovations (GPI) and the nonprofit Last Prisoner Project (LPP) plan to launch a new brand, Two Joints. One percent of proceeds from Two Joints products sold in GPI’s Skymint provisioning centers will go toward LPP and its mission of advocating for criminal justice reform around cannabis crimes.

“When my partner, Jeff Radway, and I started Green Peak, we knew that Michigan was marching towards legalization, and we thought a big part of that effort needed to include criminal-record expungement of nonviolent marijuana offenders,” said Joe Neller, GPI’s co-founder and chief government affairs officer.

RELATED: Where Are They Now: Q&A with Jeff Radway

Green Peak’s team was looking for an organization to partner with on this effort, Neller said, and while many said they wouldn’t accept money from cannabis companies, LPP said it would.

LPP works with industry partners on brands, as it has with GPI on Two Joints, and in other ways, said Sarah Gersten, executive director and general counsel for LPP. “We have several industry partners that simply choose to donate proceeds from their total revenue to the organization,” she said. “We have folks that assist us in giving back through mentorship programs, with our reentry program, providing education, things like that.”

Photo courtesy of Green Peak Innovations

To start, Two Joints products will be available in Green Peak’s Skymint dispensaries in Ann Arbor, Bay City, Lansing and White Cloud, Mich. The dispensaries will package and sell Two Joints-branded eighth-ounce bags of flower and pre-rolls with LPP’s logo and website printed on the packaging, indexed at a lower value than Skymint’s other eighths and pre-rolls. This scope could expand in the future, Neller said.

“We’re really excited about the partnership,” Neller said. “We think it’s an important cause, and it feels good to do good. When you look at the arrest statistics, it’s shameful that Michigan still [arrested] over 20,000 people every year for possession leading up to the legalization in 2018. We’re almost a year and a half after that, and our state still hasn’t done anything on criminal-record expungement or clemency for what are largely very small infractions. And it’s time that we do something about it.”

Laurie Gregory, GPI’s chief brand and product officer, shed some light on the concept of packaging two pre-rolls and the Two Joints name. “The name Two Joints refers to the shareable nature of our products, which inspire our customers to ask themselves, ‘What would you do with two joints?’” she said. “We have come a long way since the 1960s, when possessing just two joints could result in a 10-year jail sentence. At the same time, we know how far we have to go, and we are eager to help Last Prisoner Project shed light on wrongful incarcerations and rebuild lives.”

Neller, who worked in traditional health care lobbying before joining Michigan’s medical marijuana industry in 2017, said he and his team have been working to pass a series of criminal-record “clean slate” and expungement bills in the state, House Bills 4980-4985. Taking into account factors such as the type and number of crimes committed, the bills would clear convictions of and increase expungement eligibility for nonviolent crimes. Marijuana offenses that were committed before adult-use legalization but that are no longer offenses post-legalization would be eligible for expungement, Neller said.

RELATED: How Green Peak Innovations Is Navigating the Early Days of Medical Cannabis in Michigan

Team members at Green Peak have helped LPP with mentorship and job placement, including jobs at Green Peak, Gersten said. They have also lent government-relations help on policy initiatives and lobbying.

Ahead of the launch of Two Joints, LPP continues its involvement in multiple other industry partnerships. LPP board member Damian Marley and Ocean Grown Extracts recently launched a product called “Evidence.” “The product packaging is made to look like an evidence bag in a criminal offense of marijuana,” Gersten said. And 4Front Ventures and its Mission Dispensaries have teamed up with LPP on a letter-writing campaign, in addition to other initiatives like recently manufacturing hand sanitizer at one of their manufacturing facilities and helping LPP donate it to correctional facilities.

For months, LPP has been working to help clear jails of prisoners amid the coronavirus pandemic. “We set up a pretty robust compassionate-release program where we pair our constituents—particularly those that might be at risk to the virus, those that are part of the aging population, have underlying health conditions—with pro bono attorneys to actually take on their compassionate-release cases,” Gersten said. “And we’re just starting to see the fruits of those labors.”

LPP had to wait 30 days after submitting a request with the Bureau of Prisons to take cases to court, she said, but judges are now starting to decide on compassionate-release cases.

“We are hopeful that judges and executives that have power in the states over releasing people will start to see the urgent need to do that and [we’ll] actually start to see some more movement on the prison level,” Gerseten said. “… We have successfully now engaged some industry partners to get donations into facilities, so we had a couple partnerships where we got hand sanitizer and masks into correctional facilities for inmates.”

Published at Sat, 23 May 2020 10:00:00 +0000

California Offers License Fee Deferrals to Cannabis Businesses, Massachusetts Adult-Use Dispensaries Prepare to Reopen with Curbside Pickup: Week in Review

California Offers License Fee Deferrals to Cannabis Businesses, Massachusetts Adult-Use Dispensaries Prepare to Reopen with Curbside Pickup: Week in Review

The week of May 24, Michigan’s vertically integrated Green Peak Innovations (GPI) and the nonprofit Last Prisoner Project (LPP) plan to launch a new brand, Two Joints. One percent of proceeds from Two Joints products sold in GPI’s Skymint provisioning centers will go toward LPP and its mission of advocating for criminal justice reform around cannabis crimes.

“When my partner, Jeff Radway, and I started Green Peak, we knew that Michigan was marching towards legalization, and we thought a big part of that effort needed to include criminal-record expungement of nonviolent marijuana offenders,” said Joe Neller, GPI’s co-founder and chief government affairs officer.

RELATED: Where Are They Now: Q&A with Jeff Radway

Green Peak’s team was looking for an organization to partner with on this effort, Neller said, and while many said they wouldn’t accept money from cannabis companies, LPP said it would.

LPP works with industry partners on brands, as it has with GPI on Two Joints, and in other ways, said Sarah Gersten, executive director and general counsel for LPP. “We have several industry partners that simply choose to donate proceeds from their total revenue to the organization,” she said. “We have folks that assist us in giving back through mentorship programs, with our reentry program, providing education, things like that.”

Photo courtesy of Green Peak Innovations

To start, Two Joints products will be available in Green Peak’s Skymint dispensaries in Ann Arbor, Bay City, Lansing and White Cloud, Mich. The dispensaries will package and sell Two Joints-branded eighth-ounce bags of flower and pre-rolls with LPP’s logo and website printed on the packaging, indexed at a lower value than Skymint’s other eighths and pre-rolls. This scope could expand in the future, Neller said.

“We’re really excited about the partnership,” Neller said. “We think it’s an important cause, and it feels good to do good. When you look at the arrest statistics, it’s shameful that Michigan still [arrested] over 20,000 people every year for possession leading up to the legalization in 2018. We’re almost a year and a half after that, and our state still hasn’t done anything on criminal-record expungement or clemency for what are largely very small infractions. And it’s time that we do something about it.”

Laurie Gregory, GPI’s chief brand and product officer, shed some light on the concept of packaging two pre-rolls and the Two Joints name. “The name Two Joints refers to the shareable nature of our products, which inspire our customers to ask themselves, ‘What would you do with two joints?’” she said. “We have come a long way since the 1960s, when possessing just two joints could result in a 10-year jail sentence. At the same time, we know how far we have to go, and we are eager to help Last Prisoner Project shed light on wrongful incarcerations and rebuild lives.”

Neller, who worked in traditional health care lobbying before joining Michigan’s medical marijuana industry in 2017, said he and his team have been working to pass a series of criminal-record “clean slate” and expungement bills in the state, House Bills 4980-4985. Taking into account factors such as the type and number of crimes committed, the bills would clear convictions of and increase expungement eligibility for nonviolent crimes. Marijuana offenses that were committed before adult-use legalization but that are no longer offenses post-legalization would be eligible for expungement, Neller said.

RELATED: How Green Peak Innovations Is Navigating the Early Days of Medical Cannabis in Michigan

Team members at Green Peak have helped LPP with mentorship and job placement, including jobs at Green Peak, Gersten said. They have also lent government-relations help on policy initiatives and lobbying.

Ahead of the launch of Two Joints, LPP continues its involvement in multiple other industry partnerships. LPP board member Damian Marley and Ocean Grown Extracts recently launched a product called “Evidence.” “The product packaging is made to look like an evidence bag in a criminal offense of marijuana,” Gersten said. And 4Front Ventures and its Mission Dispensaries have teamed up with LPP on a letter-writing campaign, in addition to other initiatives like recently manufacturing hand sanitizer at one of their manufacturing facilities and helping LPP donate it to correctional facilities.

For months, LPP has been working to help clear jails of prisoners amid the coronavirus pandemic. “We set up a pretty robust compassionate-release program where we pair our constituents—particularly those that might be at risk to the virus, those that are part of the aging population, have underlying health conditions—with pro bono attorneys to actually take on their compassionate-release cases,” Gersten said. “And we’re just starting to see the fruits of those labors.”

LPP had to wait 30 days after submitting a request with the Bureau of Prisons to take cases to court, she said, but judges are now starting to decide on compassionate-release cases.

“We are hopeful that judges and executives that have power in the states over releasing people will start to see the urgent need to do that and [we’ll] actually start to see some more movement on the prison level,” Gerseten said. “… We have successfully now engaged some industry partners to get donations into facilities, so we had a couple partnerships where we got hand sanitizer and masks into correctional facilities for inmates.”

Published at Sat, 23 May 2020 12:30:00 +0000

CV Sciences Inc (OTCMKTS:CVSI) Posts A Drop Of 45% In Q1 2020 Results: E-Commerce Sales Surges By 24% And Accounts For 24% Of The Total Net Revenues

CV Sciences Inc (OTCMKTS:CVSI) Posts A Drop Of 45% In Q1 2020 Results: E-Commerce Sales Surges By 24% And Accounts For 24% Of The Total Net Revenues

CV Sciences Inc (OTCMKTS:CVSI) has posted revenues of $8.3 million in Q1 2020. It is a drop of 45% when compared to the same period last year. However, its e-commerce sales have surged by 15% when compared to the same period of 2019. E-commerce sales accounted for 24% of the overall net revenues.

Streamlines operations

CV Sciences has streamlined the operations in the past few months to move in the right direction of achieving robust growth during the global health crisis. The company maintains its distribution and production facilities amid coronavirus crisis and delivers high-quality hemp-based cannabidiol products to the customers.

Improves operational efficiency

Chief Executive Officer of CV Sciences, Joseph Dowling, said the company is confident of maintaining a positive outlook in the long term because it has taken proactive measures in the current challenging environment. It has mitigated the impact of coronavirus related effects with the help of its e-commerce arm. The company is on track to broaden its product line and maintain vertical categories. Joseph said the company implemented cost-cutting measures in the past several months to improve operational efficiency and boost earnings.

Preparing to tackle macroeconomic challenges

CV Sciences is also preparing to tackle the macroeconomic and other industry challenges. It is exploring significant opportunities for expanding the distribution and enters into new categories to realize growth. The company is also mobilizing sufficient financial resources to put the company on the growth path amid the challenges created by the coronavirus crisis and short term challenges that affect the CBD market. It is maintaining the lead in the hemp-derived cannabidiol market. The company has the right infrastructure to promote growth and derive rich dividends for the shareholders going forward.

Receives notice of allowance from USPTO

CV Sciences has received the notice of allowance from the US Patents and Trademarks Office for its patent that covers methods to treat smokeless tobacco addiction with the help of pharmaceutical formulations that comprise nicotine and CBD. According to Dowling, it’s IP, and proprietary technology provides significant opportunities for commercializing the cannabidiol based pharmaceutical drug. The market for smokeless tobacco addiction treatment expects to reach over $2 billion.

The retail store count of CV Sciences has surged to 5,799 stores across the nation as of March 31, 2020, when compared to 3,308 stores for the same period last year.

Published at Thu, 21 May 2020 12:05:15 +0000

Khiron Life Sciences Corp (OTCMKTS:KHRNF) Announces Receipt Of First Medical Cannabis Prescriptions For Project Twenty21 Participating Patients In The UK

Khiron Life Sciences Corp (OTCMKTS:KHRNF) Announces Receipt Of First Medical Cannabis Prescriptions For Project Twenty21 Participating Patients In The UK

Khiron Life Sciences Corp (OTCMKTS:KHRNF) has received the first medical cannabis prescriptions for Project Twenty21 patients in the UK. The clinics and doctors’ participating in the Project Twenty21 can now access Khiron branded EU GMP medical cannabis.

Project Twenty21 evaluates the effectiveness of medical cannabis

Project Twenty21 is initiated to investigate the tolerability and effectiveness of medical cannabis. After first announcing the participation in November 2019, Khiron prepares to supply for the Project Twenty21. Eminent personalities like Dr. Maria Fernanda Arboleda, Global Director (Medical Services) support the EU GMP medical cannabis supply. Khiron leverages its expertise gained from Colombia in making therapeutic recommendations and educational materials for the Project Twenty21, which expects to enroll 20,000 patients.

Professor David Nutt, who leads the project, said Khiron’s involvement in the Project Twenty21 significantly enhances formulary. The patients can get quick access to medical cannabis with the help of support extended by the team of Khiron.

Flexible to source medical cannabis from multiple nations

President of Khiron Europe, Tejinder Virk, said the receipt of the first prescriptions in the UK is a testament for its internationally diversified supply chain strategy and regulatory strengths. The company has the flexibility to get medical cannabis from several nations worldwide and ensure providing quality cannabis products at reasonable prices. Khiron has achieved milestones like virtual consultations implementation in the UK. It is also committed to mail order fulfillment and ensures healthy outcomes for the patients.

Signs a distribution deal with Medlive

Chris Naprawa, the president of Khiron, will present live at the fourth International cannabis virtual conference, which will be held at 11:40 AM ET on May 12, 2020. The company signed an exclusive accord with the distributor – Medlive, that serves three thousand hospitals and clinics in Brazil. It also entered a distribution agreement with Locatel for the distribution of medical cannabis in Colombia. Locatel serves more than two million patients in Colombia with healthcare products.

Other highlights

Khiron is the only company qualified to export THC products. It has received full authorization for the manufacture of low and high THC medical cannabis in Colombia on March 20, 2020. The company is operating health centers and cultivation facilities to cater to the needs of patients using the exemption granted by the Colombian government.

Published at Fri, 22 May 2020 12:19:48 +0000

Indiva Begins Distribution to New Brunswick and Manitoba

Indiva Begins Distribution to New Brunswick and Manitoba

Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce that it has secured distribution rights to ship its premium cannabis products to New Brunswick and Manitoba. These two new agreements extend Indiva’s distribution network to eight provinces. Indiva’s first shipments to Manitoba include INDIVA™ pre-rolls and THC capsules, and Bhang® Chocolate. Indiva expects that INDIVA™ and Bhang® products will be available in Manitoba stores within the next two weeks. New Brunswick recently received Bhang® Chocolate, which is now available for purchase at www.cannabis-nb.com.

“We are proud to continue to grow our distribution network across Canada,” Niel Marotta, Indiva’s President and Chief Executive Officer, said. “As of today, we are nearly a nationwide producer and distributor of cannabis and cannabis-infused products. We are delighted to bring our top-selling products to New Brunswick and Manitoba. We are proud to add to both provinces’ growing collections and bring our beloved Bhang® and INDIVA™ brands to more Canadians.”

ABOUT INDIVA

Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, and edible products and provides production and manufacturing services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Wana Sour Gummies, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt and other Powered by INDIVA™ products through license agreements, partnerships and joint ventures. Click here to connect with Indiva onLinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.

CONTACTS

MEDIA CONTACT
Kate Abernathy, Vice President of Marketing and Communications
Phone: 613-296-5764
Email: kabernathy@indiva.com

INVESTOR CONTACT
Steve Low, Investor Relations
Phone: 647-620-5101
Email: slow@indiva.com

DISCLAIMER AND READER ADVISORY

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company’s future operations, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

Primary Logo

Published at Thu, 21 May 2020 11:02:23 +0000